United States ex rel. McCoy v. California Medical Review, Inc.

133 F.R.D. 143, 90 Daily Journal DAR 14240, 18 Media L. Rep. (BNA) 2158, 1990 U.S. Dist. LEXIS 16558, 1990 WL 193619
CourtDistrict Court, N.D. California
DecidedDecember 5, 1990
DocketNo. C-88-3659-MHP
StatusPublished
Cited by6 cases

This text of 133 F.R.D. 143 (United States ex rel. McCoy v. California Medical Review, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States ex rel. McCoy v. California Medical Review, Inc., 133 F.R.D. 143, 90 Daily Journal DAR 14240, 18 Media L. Rep. (BNA) 2158, 1990 U.S. Dist. LEXIS 16558, 1990 WL 193619 (N.D. Cal. 1990).

Opinion

OPINION

PATEL, District Judge.

This action under the False Claims Amendments Act of 1986, 31 U.S.C. §§ 3729-3733, was filed by relators Guy D. McCoy, Jr. and Frank Helium on September 16, 1988. The matter is now before the court on motions by defendants and the United States to hold a hearing in camera on the fairness of a proposed settlement and to seal all briefs related to the hearing. In addition, the relators seek discovery with regard to the proposed settlement.

Having considered the memoranda and the arguments of the parties, the court DENIES the motions by the United States and the defendants to hold the settlement [145]*145hearing in camera and GRANTS plaintiffs’ request for discovery, as outlined below. BACKGROUND

Relators McCoy and Helium are former employees of defendant California Medical Review, Inc. (“CMRI”). Acting as qui tarn plaintiffs under the False Claims Amendments Act of 1986 (“Act”), 31 U.S.C. §§ 3729-3733, relators filed this action in September 1988, alleging fraudulent practices by CMRI in violation of the Act. On January 3, 1989, pursuant to 31 U.S.C. § 3730(b)(4)(A), the United States entered its appearance and took over the action. The United States filed its first amended complaint on March 22, 1989.

The United States, suing on behalf of the Health Care Financing Administration (“HCFA”) of the Department of Health and Human Services (“HHS”), seeks damages and civil penalties arising from false claims and reports allegedly submitted by CMRI to HCFA. ■ Under 42 U.S.C. §§ 1320c-l to 1320c-13, HCFA is responsible for administering certain aspects of the Medicare program, in particular the Prospective Payment System (“PPS”). Under the PPS scheme, each state has one Peer Review Organization (“PRO”), which contracts with HHS to monitor and review hospital discharge payments under the Medicare program. The PROs review each discharge case under HCFA’s regulations, denying any inappropriate discharge payments. See 42 C.F.R. §§ 466.83-104 (1989). The crux of the United States’ case is the allegation that CMRI and its personnel, without performing this required review, fraudulently certified to HCFA that the review had been completed.

Plaintiffs allege that defendants employed a procedure called “autocertification,” which involved stamping the identification number of a CMRI Review Coordinator or District Review Manager on a discharge, although neither that CMRI employee nor any other had in fact reviewed the discharge. Second Amended Complaint, ¶1¶ 28, 31. The United States alleges that, pursuant to this autocertification system, defendants falsely claimed that 51,094 reviews were performed between August 1, 1986 and September 30, 1986. Id. at ¶ 31. Approximately 30,000 discharges were identified as reviewed by defendant Alan Snodgrass alone. Id.

The United States and defendants have now reached agreement on a proposed settlement of the civil action in this case.1 Plaintiffs McCoy and Helium oppose the proposed settlement and request discovery on the matter. The United States and defendants have moved that the hearing on the proposed settlement agreement be held in camera and that all briefs filed in connection with the hearing be sealed; plaintiffs McCoy and Helium oppose this motion.

DISCUSSION

I. The Settlement Hearing

Defendants and the United States argue that good cause exists to hold the settlement hearing in camera and to seal filings related to the hearing because publicity concerning the hearing might taint witnesses and jurors in this civil action and in the criminal prosecution of Alan Snodgrass. Defendants also assert that “if the Court does not protect the settlement approval process from disclosure, the reputations of the defendants will be falsely impugned by relators’ counsel’s assessment of the underlying facts, exposing them to serious censure and public ridicule.” Def. MPA at 5:24-6:3. Both defendants and the United States argue that neither common law nor the first amendment justifies public access to the settlement hearing.

The legislative history of the 1986 amendments to the False Claims Act indicates that they were enacted in response to a steady rise in fraud in government programs and procurement and a failure of the government to detect and prosecute such violations. S.Rep. No. 345, 99th Cong., 2d Sess., reprinted in 1986 U.S. Code Cong. & Admin.News at 5266, 5266-73. The False Claims Amendments Act was therefore designed to “enhance the Government’s ability to recover losses sustained as a result of fraud against the [146]*146Government.” Id. at 5266. One of the principal features of the Act was a strengthening of the role of qui tarn plaintiffs in actions brought under the False Claims Act. See 132 Cong.Rec. 29,321 (1986) (Statement of Rep. Berman). This strengthening reflected Congress’ belief that “[i]n the face of sophisticated and widespread fraud, ... only a coordinated effort of both the Government and the citizenry will decrease this wave of defrauding public funds.” S.Rep. No. 345, supra, at 5267.

31 U.S.C. § 3730 gives the government the right to intervene in civil actions brought by individual or qui tam plaintiffs under the False Claims Amendments Act. With regard to settlement, the Act provides as follows:

The Government may settle the action with the defendant notwithstanding the objections of the person initiating the action if the court determines, after a hearing, that the proposed settlement is fair, adequate, and reasonable under all the circumstances. Upon a showing of good cause, such hearing may be held in camera.

31 U.S.C. § 3730(c)(2)(B) (emphasis added).

The language of the statute makes it clear that there is a presumption in favor of open settlement hearings. Settlement hearings will be held in camera only when there has been a showing of good cause; the burden to show good cause is clearly on the moving party.

The term “good cause” is not defined in the Act. Moreover, neither the parties nor the court have been able to identify any legislative history which sheds light on what Congress intended when it employed this term. It is axiomatic that when a term of common currency such as “good cause” is not defined in a statute or its legislative history, the court may look for guidance to other statutes and authority where the term has been defined.

The court finds decisional authority concerning Federal Rule of Civil Procedure 26(c) to be especially enlightening.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

USA v. Everglades College, Inc.
855 F.3d 1279 (Eleventh Circuit, 2017)
New Mexico State Investment Council v. Weinstein
2016 NMCA 069 (New Mexico Court of Appeals, 2016)
Hemphill v. San Diego Ass'n of Realtors, Inc.
225 F.R.D. 616 (S.D. California, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
133 F.R.D. 143, 90 Daily Journal DAR 14240, 18 Media L. Rep. (BNA) 2158, 1990 U.S. Dist. LEXIS 16558, 1990 WL 193619, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-mccoy-v-california-medical-review-inc-cand-1990.